Manufacturers of injectable-grade peptide APIs and finished injectable drug products for pharmaceutical and clinical use. Injectable peptide products require stringent quality controls beyond those for research-grade materials, including bioburden testing, endotoxin testing (LAL assay per USP <85>), sterility assurance per USP <71>, and particulate matter testing per USP <788> and <789>. Lyophilized (freeze-dried) injectable peptide products require validated lyophilization cycles with documented temperature mapping and moisture content analysis. FDA's 2024-2025 warning letters have specifically highlighted risks in injectable peptide products, particularly around sterility assurance and non-sterile manufacturing conditions for products labeled as sterile injectables. Showing 10 listed suppliers.
Our directory lists suppliers offering injectable apis services across North America, Europe, Global, Asia regions. Supplier types include CDMO, Pharmacy, Research Supplier. Browse individual profiles below for detailed capability information, manufacturing standards, and quality documentation.
Directory listing last reviewed July 2026.